Aethlon Medical, Inc. (AEMD)
After hours:
Chart Events
Performance Outlook
| Previous Close | 1.3400 |
| Open | 1.3100 |
| Bid | 1.3100 x 1000 |
| Ask | 1.3500 x 1800 |
| Day's Range | 1.3100 - 1.3900 |
| 52 Week Range | 0.8800 - 5.9900 |
| Volume | |
| Avg. Volume | 4,481,741 |
| Market Cap | 31.144M |
| Beta (5Y Monthly) | N/A |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.6110 |
| Earnings Date | Nov 07, 2022 - Nov 11, 2022 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 7.00 |
Fair Value
Subscribe to Yahoo Finance Plus to view Fair Value for AEMD
Related Research
- Aethlon Medical, Inc.Analyst Report: Johnson & JohnsonJohnson & Johnson is the world's largest and most diverse healthcare firm. Three divisions make up the firm: pharmaceutical, medical devices and diagnostics, and consumer. The drug and device groups represent close to 80% of sales and drive the majority of cash flows for the firm. The drug division focuses on the following therapeutic areas: immunology, oncology, neurology, pulmonary, cardiology, and metabolic diseases. The device segment focuses on orthopedics, surgery tools, vision care, and a few smaller areas. The last segment of consumer focuses on baby care, beauty, oral care, over-the-counter drugs, and women’s health. Geographically, just over half of total revenue is generated in the United States.RatingFair ValueEconomic Moat5 days agoMorningstar
- Insider Monkey
10 Healthcare and Biotech Stocks to Buy Amid Monkeypox Threat
In this article, we will look at 10 healthcare and biotech stocks to buy amid the monkeypox threat. If you want to explore similar healthcare and biotech stocks, you can also take a look at 5 Healthcare and Biotech Stocks to Buy Amid Monkeypox Threat. In May of 2022, the first case of the monkeypox […]
- Benzinga
Aethlon Medical To Start Lab Studies For Hemopurifier For Monkeypox
Aethlon Medical Inc (NASDAQ: AEMD) said it is commissioning a new in vitro binding experiment to confirm that the Hemopurifier effectively captures the current strain of the monkeypox virus. The Hemopurifier is an extracorporeal (i.e., outside of the body) blood filtration device designed to selectively remove harmful particles from the circulatory system using lectin affinity agents. In 2008, the company conducted an in vitro study demonstrating that the Hemopurifier effectively bound and remov
- PR Newswire
Aethlon Medical Announces First Quarter Financial Results and Provides Corporate Update
Aethlon Medical, Inc. (Nasdaq: AEMD), a medical therapeutic company focused on developing products to diagnose and treat cancer and life threatening infectious diseases, today reported financial results for its first quarter ended June 30, 2022 and provided an update on recent developments.
